The 7th US Circuit Court of Appeals on Monday, March 23, affirmed a win for the Chicago Mercantile Exchange (CME) Group’s Chicago Board of Trade (CBOT) in the antitrust lawsuit that US Futures Exchange filed in 2004.
USFE, formed by Swiss-German Eurex Exchange, filed the suit soon after it started competing with CBOT as an exchange for US Treasury futures. At the time, the CBOT and CME were separate entities.
The suit contends that two big Chicago futures exchanges, now both part of CME Group, illegally colluded to prevent a foreign rival, Eurex, from intruding on their home turf. Eurex’s US exchange filed the suit in October 2003 against the Chicago Board of Trade and the Chicago Mercantile Exchange. It later revised the suit to accuse CME and CBOT of manipulating regulators and politicians to sabotage Eurex’s bid.
CME denies the allegations and is making a last-ditch effort to have the suit thrown out. It says Eurex’s US venture, called US Futures Exchange and now fully owned by Deutsche Boerse AG, failed because of its own missteps.
“After more than a decade, this lawsuit is still no substitute for USFE’s lack of a compelling business strategy,” a CME spokeswoman said. “This case is simply USFE’s and Eurex’s attempt to shift blame for their own failure.”
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan